Skip to main content
Equibles

Inspire Advisors, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1810558 Meridian, ID
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$92,776
+$33,921 QoQ
Shares Held
19,995
-5.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 98 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Inspire Advisors, LLC holds $5,818,365 across 11 Biotechnology names. GALT ranks #10 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 16,711 $1,894,358
2 CRSP
CRISPR Therapeutics AG
 19,880 $1,084,255
3 EXEL
Exelixis, Inc.
 16,370 $890,691
4 TGTX
Tg Therapeutics, Inc.
 8,271 $454,408
5 KRYS
Krystal Biotech, Inc.
 958 $356,059
6 BBIO
BridgeBio Pharma, Inc.
 3,788 $282,130
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 3,408 $277,786
8 STOK
Stoke Therapeutics, Inc.
 8,423 $275,600

All Filings in GALT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,776 19,995
2026-03-31 $58,855 21,095
2025-12-31 $87,755 21,095
2025-09-30 $89,442 21,095
2025-06-30 $44,510 21,095
2025-03-31 $25,735 21,095
2024-12-31 $27,212 21,095
2024-09-30 $31,138 11,323
2024-06-30 $25,589 11,323
2024-03-31 $27,061 11,323
2023-12-31 $18,796 11,323